Brian Casserly

2.4k total citations · 1 hit paper
55 papers, 1.7k citations indexed

About

Brian Casserly is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Brian Casserly has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 17 papers in Epidemiology and 9 papers in Physiology. Recurrent topics in Brian Casserly's work include Sepsis Diagnosis and Treatment (11 papers), Cystic Fibrosis Research Advances (10 papers) and Respiratory Support and Mechanisms (5 papers). Brian Casserly is often cited by papers focused on Sepsis Diagnosis and Treatment (11 papers), Cystic Fibrosis Research Advances (10 papers) and Respiratory Support and Mechanisms (5 papers). Brian Casserly collaborates with scholars based in United States, Ireland and Australia. Brian Casserly's co-authors include Nick Ward, Alfred Ayala, Mitchell M. Levy, Elizabeth O. Harrington, Timothy Hla, Teresa Sánchez, Gary Phillips, Athanasia Skoura, Tiffany M. Osborn and Christa Schorr and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Stroke and Journal of Applied Physiology.

In The Last Decade

Brian Casserly

51 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion

2014 322 citations Brian Casserly, Gary Phillips et al. profile →

Peers

Countries citing papers authored by Brian Casserly

Since Specialization

Citations

This map shows the geographic impact of Brian Casserly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Casserly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Casserly more than expected).

Fields of papers citing papers by Brian Casserly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Casserly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Casserly. The network helps show where Brian Casserly may publish in the future.

Co-authorship network of co-authors of Brian Casserly

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Casserly. A scholar is included among the top collaborators of Brian Casserly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Casserly. Brian Casserly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advanced Imaging and Occupational History in the Diagnosis of Bird Fancier's Lung: A Case Report 2025 ·Cureus ·(unknown), (unknown), Brian Casserly, (unknown), Insha Amin	0
2	Steps Ahead: Optimising physical activity in adults with cystic fibrosis: A pilot randomised trial using wearable technology, goal setting and text message feedback 2022 ·Journal of Cystic Fibrosis ·(unknown), Audrey Tierney, (unknown), (unknown), (unknown), (unknown), Ali Sheikhi, Cathal Walsh, Brenda Button, Brian Casserly, Róisín Cahalan	7
3	Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome 2019 ·Irish Journal of Medical Science (1971 -) ·(unknown), (unknown), Brian Casserly	9
4	A pyo-hydropneumothorax with sepsis, secondary to Gardnerella vaginalis infection in a post-partum female 2019 ·Respiratory Medicine Case Reports ·(unknown), (unknown), Brian Casserly, N.H. O’Connell, (unknown)	7
5	Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of Ireland 2018 ·Annals of the American Thoracic Society ·L. Kirwan, (unknown), M. G. Harrington, (unknown), Shijun Zhou, Brian Casserly, Charles G. Gallagher, Peter Greally, Cedric Gunaratnam, (unknown), Barry Linnane, Noel G. McElvaney, Edward F. McKone, Paul McNally, D. Mullane, Muireann Ní Chróinín, Michael O’Mahony, Barry J. Plant, Abaigeal Jackson	46
6	How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease? 2017 ·American Journal of Respiratory and Critical Care Medicine ·Kai Michael Beeh, Pierre‐Régis Burgel, Frits M.E. Franssen, José Luís López-Campos, Stelios Loukides, John R. Hurst, Matjaž Fležar, Charlotte Suppli Ulrik, Fabiano Di Marco, Daiana Stolz, Arschang Valipour, Brian Casserly, Björn Ställberg, Κonstantinos Κostikas, Jadwiga A. Wedzicha	58
7	End-Expiratory Volume and Oxygenation: Targeting PEEP in ARDS Patients 2015 ·Lung ·Brian Casserly, F. Dennis McCool, Jean Saunders, (unknown), Mitchell M. Levy	4
8	Effusion under the microscope 2015 ·Monaldi Archives for Chest Disease ·Sy Giin Chong, (unknown), (unknown), (unknown), Brian Casserly	2
9	Rapid resolution of pulmonary Langerhans cell histiocytosis 2013 ·BMJ Case Reports ·Sy Giin Chong, (unknown), (unknown), Brian Casserly	0
10	Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign 2012 ·Intensive Care Medicine ·Brian Casserly, Herwig Gerlach, Gary Phillips, Stanley Lemeshow, John C. Marshall, Tiffany M. Osborn, Mitchell M. Levy	42
11	Multimarker Panels in Sepsis 2011 ·Critical Care Clinics ·Brian Casserly, (unknown), Mitchell M. Levy	21
12	Treatment Options for Cystic Fibrosis: State of the Art and Future Perspectives 2011 ·Reviews on Recent Clinical Trials ·(unknown), Eric Gartman, Brian Casserly	10
13	Reducing Mortality in Severe Sepsis and Septic Shock 2011 ·Seminars in Respiratory and Critical Care Medicine ·Andrew Levinson, Brian Casserly, Mitchell M. Levy	35
14	C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade 2011 ·Life Sciences ·Brian Casserly, (unknown), Alexander Vang, Elizabeth O. Harrington, James R. Klinger, Sharon Rounds, Gaurav Choudhary	8
15	The Role of Natriuretic Peptides in Inflammation and Immunity 2010 ·Recent Patents on Inflammation & Allergy Drug Discovery ·Brian Casserly, (unknown), Eric Gartman	14
16	Influence of Body Mass Index on Changes in Disease-Specific Quality of Life of Veterans Completing Pulmonary Rehabilitation 2010 ·Journal of Cardiopulmonary Rehabilitation and Prevention ·(unknown), Paul A. Pirraglia, Brian Casserly, Linda Nici	1
17	Stabilization of Lung Function and Clinical Symptoms in a Patient with Cystic Fibrosis (CF) After Institution of Infliximab: A Monoclonal Antibody that Binds Tumor Necrosis Factor alpha 2009 ·Lung ·Brian Casserly, Walter Donat	8
18	The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients 2008 ·Clinics in Chest Medicine ·Nick Ward, Brian Casserly, Alfred Ayala	277
19	Rottlerin causes pulmonary edema in vivo: a possible role for PKCδ 2007 ·Journal of Applied Physiology ·James R. Klinger, (unknown), Brian Casserly, Diego F. Alvarez, Judy King, Steven S. An, Gaurav Choudhary, (unknown), Rod R. Warburton, Elizabeth O. Harrington	24
20	Propofol infusion syndrome: An unusual cause of renal failure 2004 ·American Journal of Kidney Diseases ·Brian Casserly, (unknown), (unknown), (unknown), George Eisele, (unknown)	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact